☰

Megan Larson - Publications

Affiliations: 
2010-2013 Neuroscience University of Minnesota - Minneapolis 
Tree Info Grants Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Larson ME, Greimel SJ, Amar F, LaCroix M, Boyle G, Sherman MA, Schley H, Miel C, Schneider JA, Kayed R, Benfenati F, Lee MK, Bennett DA, Lesné SE. Selective lowering of synapsins induced by oligomeric α-synuclein exacerbates memory deficits. Proceedings of the National Academy of Sciences of the United States of America. PMID 28533388 DOI: 10.1073/Pnas.1704698114  0.693
2017 Amar F, Sherman MA, Rush T, Larson M, Boyle G, Chang L, Götz J, Buisson A, Lesné SE. The amyloid-β oligomer Aβ*56 induces specific alterations in neuronal signaling that lead to tau phosphorylation and aggregation. Science Signaling. 10. PMID 28487416 DOI: 10.1126/Scisignal.Aal2021  0.787
2016 Sherman MA, LaCroix M, Amar F, Larson ME, Forster C, Aguzzi A, Bennett DA, Ramsden M, Lesné SE. Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 9647-58. PMID 27629715 DOI: 10.1523/Jneurosci.1899-16.2016  0.805
2016 Lesne S, Amar F, Sherman M, Rush T, Larson M, Chang L, Götz J, Schneider J, Bennett D, Ashe K, Buisson A. Specific alterations of tau phosphorylation and neuronal signaling induced by the amyloid-β oligomer Aβ*56 Neurobiology of Aging. 39: S27. DOI: 10.1016/J.Neurobiolaging.2016.01.117  0.766
2014 Fowler SW, Chiang AC, Savjani RR, Larson ME, Sherman MA, Schuler DR, Cirrito JR, Lesné SE, Jankowsky JL. Genetic modulation of soluble Aβ rescues cognitive and synaptic impairment in a mouse model of Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 7871-85. PMID 24899710 DOI: 10.1523/Jneurosci.0572-14.2014  0.528
2013 Fowler S, Chiang A, Savjani R, Larson M, Schuler D, Cirrito J, Lesne S, Jankowsky J. Genetic modulation of soluble Aβ rescues cognitive and synaptic impairment in a mouse model of AD Molecular Neurodegeneration. 8: O30. DOI: 10.1186/1750-1326-8-S1-O30  0.8
2012 Larson M, Sherman MA, Amar F, Nuvolone M, Schneider JA, Bennett DA, Aguzzi A, Lesné SE. The complex PrP(c)-Fyn couples human oligomeric Aβ with pathological tau changes in Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 16857-71a. PMID 23175838 DOI: 10.1523/Jneurosci.1858-12.2012  0.846
2012 Larson ME, Sherman MA, Greimel S, Kuskowski M, Schneider JA, Bennett DA, Lesné SE. Soluble α-synuclein is a novel modulator of Alzheimer's disease pathophysiology. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 10253-66. PMID 22836259 DOI: 10.1523/Jneurosci.0581-12.2012  0.819
2012 Larson ME, Lesné SE. Soluble Aβ oligomer production and toxicity. Journal of Neurochemistry. 120: 125-39. PMID 22121920 DOI: 10.1111/j.1471-4159.2011.07478.x  0.828
2012 Larson M, Sherman M, Nuvolone M, Schneider J, Bennett D, Aguzzi A, Lesne S. Human Aβ dimers bind to PrPc to activate Fyn in Alzheimer's disease Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.1159  0.77
2011 Larson M, Sherman M, Kuskowski M, Schneider J, Bennett D, Lesne S. Differential contribution of soluble forms of α-synuclein, TDP-43 and PrPc to Alzheimer's disease-associated cognitive impairment Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1124  0.774
Show low-probability matches.